These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 5685308)

  • 1. [Treatment with aspartic acid in hepatic coma caused by hyperammonemia].
    Fodor O; Popescu S; Grigoraş D; Barbarino F
    Med Interna (Bucur); 1968 Jul; 20(7):781-5. PubMed ID: 5685308
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of hepatic cirrhosis and hepatic coma with drugs having the capacity of lowering the blood ammonia levels].
    Müting D
    Clin Ter; 1967 Aug; 42(4):289-97. PubMed ID: 5608820
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention and therapy of hepatic coma].
    Szám I
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):65-8. PubMed ID: 5501431
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of severe hyperammonemia].
    Leonhardt H; Bungert HJ
    Med Klin; 1972 Aug; 67(32):1052-6. PubMed ID: 5070916
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathogenesis and therapy of exogenous hepatic coma].
    Leonhardt H
    Fortschr Med; 1973 Jan; 91(1):35-8. PubMed ID: 4699340
    [No Abstract]   [Full Text] [Related]  

  • 7. Cirrhosis, hyperammonemia and Lactulose.
    Rottiers R; Van Egmond J; Verbruggen R; Dierick G; Vermeulen A; Standaert L; De Groote J; Demeulenaere L
    Tijdschr Gastroenterol; 1968; 11(2):123-39. PubMed ID: 5679042
    [No Abstract]   [Full Text] [Related]  

  • 8. [The treatment of hepatic encephalopathy with Hepa-Mertz].
    Podymova SD; Bueverov AO; Nadinskaia MIu
    Ter Arkh; 1995; 67(6):45-7. PubMed ID: 7667779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research on the ammonium-binding action of aspartic acid in hepatic diseases].
    FODOR O; BORDA M; MANASIA M; SANTAY I
    Rev Int Hepatol; 1960; 10():895-908. PubMed ID: 13700435
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heterologous pig liver perfusion in hepatic coma].
    Flatmark A; Aune S; Otnes B; Nesbakken R; Ro J; Schistad G; Lie M; Raeder M; Jakobsen A; Skulberg P; Lilleaasen P; Gjone E
    Tidsskr Nor Laegeforen; 1969 Jun; 89(11):809-13. PubMed ID: 5793594
    [No Abstract]   [Full Text] [Related]  

  • 11. L-ornithine-L-aspartate infusion efficacy in hepatic encephalopathy.
    Ahmad I; Khan AA; Alam A; Dilshad A; Butt AK; Shafqat F; Malik K; Sarwar S
    J Coll Physicians Surg Pak; 2008 Nov; 18(11):684-7. PubMed ID: 18983791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in arterial blood ammonia levels in cirrhosis. Study during and after mannitol lavage in post-hemorrhagic hepatic encephalopathy].
    Doffoel M; Kopferschmitt J; Coumaros D; Girard M; Bockel R
    Nouv Presse Med; 1978 Sep; 7(29):2575. PubMed ID: 309107
    [No Abstract]   [Full Text] [Related]  

  • 13. [Behavior of ammonia in cirrhosis and hepatic coma].
    Rodríguez Cuartero A; Candel Delgado JM; Barcelona Martín F; Mora Lara RJ
    Rev Esp Enferm Apar Dig; 1972 Dec; 38(8):957-66. PubMed ID: 4648378
    [No Abstract]   [Full Text] [Related]  

  • 14. Helicobacter pylori, hyperammonemia, and hepatic encephalopathy: is there a correlation?
    Rinaldi V; Zullo A; Diana F; Capocaccia L
    Am J Gastroenterol; 1997 Apr; 92(4):723-4. PubMed ID: 9128348
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current views on the therapy of hepatic coma].
    Ziegler K
    Z Gesamte Inn Med; 1970 Apr; 25(8):341-3. PubMed ID: 4331690
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of hyperammoniemia].
    Nordmann R
    Dtsch Med Wochenschr; 1969 Jan; 94(5):230-1. PubMed ID: 5762228
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic encephalopathy, hyperammonemia, and ammonia toxicity. Papers presented at the International Symposium on Cirrhosis, Hyperammonemia and hepatic encephalopathy. Valencia, Spain, January 24-27, 1994.
    Adv Exp Med Biol; 1994; 368():1-205. PubMed ID: 7740999
    [No Abstract]   [Full Text] [Related]  

  • 19. [Amino acids prevent hepatic encephalopathy. Ornithine-aspartate in hyperammonemia--results of a study].
    Hartung HD
    Fortschr Med; 1989 Mar; 107(8):56. PubMed ID: 2651255
    [No Abstract]   [Full Text] [Related]  

  • 20. [Glutamic acid gamma-ethyl ester in high doses in the treatment of high blood ammonia levels in severe hepatic failure].
    Santagati G; Zibetti G; Grignani A
    Minerva Med; 1978 Apr; 69(20):1367-74. PubMed ID: 566393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.